A tool for precision medicine in stroke emergencies
Strokecopilot: A Precision Medicine Tool in the Stroke Emergency
University Hospital, Strasbourg, France · NCT05534295
This study is testing a new web tool called Strokecopilot to see if it can help doctors make better treatment decisions for adults having a stroke in emergency situations.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France (other) |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT05534295 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the development and application of Strokecopilot, a web application designed to assist in the management of ischemic stroke patients in emergency settings. The tool utilizes an algorithm that contextualizes patient data against a backdrop of evidence-based medicine references, helping healthcare providers make informed decisions regarding intravenous thrombolysis and mechanical thrombectomy. By integrating evolving knowledge in stroke management, the application aims to enhance the precision of treatment selection for patients experiencing cerebrovascular accidents. The study involves adult patients admitted to the thrombolysis unit at the University Hospital of Strasbourg over a specified period.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have been admitted to the thrombolysis unit at the University Hospital of Strasbourg.
Not a fit: Patients who have opted out of data usage for scientific research will not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could significantly improve treatment outcomes for stroke patients by enabling more personalized and effective management strategies.
How similar studies have performed: While the approach of using decision support tools in stroke management is gaining traction, the specific application of Strokecopilot represents a novel integration of precision medicine in this field.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: - Adult patient (\>18 years old) admitted to the thrombolysis unit of the University Hospital of Strasbourg from January 01, 2017 to December 31, 2021 Exclusion criteria: - Subjects who have expressed their opposition to the use of their data for scientific research purposes.
Where this trial is running
Strasbourg
- Service : Unité Neurovasculaire - CHU de Strasbourg - France — Strasbourg, France (RECRUITING)
Study contacts
- Principal investigator: Valérie WOLFF, MD, PhD — Service : Unité Neurovasculaire - CHU de Strasbourg - France
- Study coordinator: Valérie WOLFF, MD, PhD
- Email: valerie.wolff@chru-strasbourg.fr
- Phone: 33 3 88 12 85 19
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cerebrovascular Accident, cerebrovascular accident, Ischemic stroke, thrombolysis channels, intravenous thrombolysis, mechanical thrombectomy